Professor of Medicine, Mayo Medical School
Gastroenterology
Dr. William J. Tremaine, MD
|
|
Give Review
Dr. William J. Tremaine works in the field of Gastroenterology. He went to University of Mississippi School of Medicine. He over the years received 4 awards: "America's Top Doctors", "Fellow (AGAF)", "Women's Health" and "Fellow (FACG)". William Tremaine is a published physician. He has 70 publications published. The most current publication "American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis." William Tremaine accepts all Medicare patients.
Publications
- American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis.
- Idiopathic inflammatory demyelinating disease of the central nervous System in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.
- Nine Medico-legal Pitfalls in Inflammatory Bowel Disease in the United States.
- The epidemiology of microscopic Colitis in olmsted county from 2002 to 2010: a population-based study.
- Letter: effectiveness of split-dose certolizumab pegol for Crohn's Disease.
- Comparative outcomes of younger and older hospitalized patients with inflammatory bowel Disease treated with corticosteroids.
- Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.
- Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative Colitis.
- Incidence of Spondyloarthropathy in Patients with Ulcerative Colitis: A Population-based Study.
- The role of the institutional review board in the oversight of the ethical aspects of human studies research.
- Symptomatic overlap between microscopic colitis and Irritable bowel syndrome: a prospective study.
- Outcomes of patients with microscopic Colitis treated with corticosteroids: a population-based study.
- Validation of the ulcerative colitis colonoscopic index of severity and its correlation with Disease activity measures.
- Incidence of Spondyloarthropathy in Patients with Crohn's Disease: A Population-based Study.
- Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970-2004).
- Natalizumab for moderate to severe Crohn's Disease in clinical practice: The Mayo Clinic Rochester experience.
- Measurement of Disease activity in ulcerative colitis: Interobserver agreement and predictors of severity.
- Crohn's Disease of the ileal pouch 16 years after proctocolectomy for ulcerative colitis.
- Perianal Crohn's Disease findings other than fistulas in a population-based cohort.
- Benefit of computed tomography enterography in Crohn's Disease: Effects on patient management and physician level of confidence.
- Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.
- Adalimumab for Crohn's Disease in clinical practice at Mayo clinic: the first 118 patients.
- Incidental findings in imaging research: evaluating incidence, benefit, and burden.
- Open-label study of adalimumab in patients with Ulcerative colitis including those with prior loss of response or intolerance to infliximab.
- Prevalence of penetrating Disease and extraintestinal manifestations of Crohn's Disease detected with CT enterography.
- Is there a threshold for the deleterious effect of smoking in Crohn's Disease?
- Small-bowel imaging in Crohn's Disease: a prospective, blinded, 4-way comparison trial.
- Equipoise, H. pylori, and Musketeers - choosing an appropriate standard clinical care regimen.
- Ethical issues concerning therapeutic studies in inflammatory bowel Disease.
- Risk factors for Colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
- Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.
- Update on the incidence and prevalence of Crohn's Disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.
- Symptomatic overlap between Irritable bowel syndrome and microscopic colitis.
- Biologics for inflammatory bowel Disease: drug approval and monitoring in the United States.
- Microscopic Colitis is not associated with cholecystectomy or appendectomy.
- Incidence and prognosis of Colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota.
- Predictive and protective factors associated with Colorectal cancer in ulcerative colitis: A case-control study.
- Risk of intestinal Cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
- Maternal and fetal outcome after colectomy for fulminant Ulcerative colitis during pregnancy: case series and literature review.
- Budesonide in the treatment of inflammatory bowel Disease: the first year of experience in clinical practice.
- Acute pancreatitis in patients with Crohn's Disease: clinical features and outcomes.
- Ethical issues, safety, and data integrity in clinical trials.
- Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel Disease.
- Endoscopic factors in the diagnosis of Colorectal dysplasia in chronic inflammatory bowel disease.
- An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's Disease.
- Early postoperative complications are not increased in patients with Crohn's Disease treated perioperatively with infliximab or immunosuppressive therapy.
- Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel Disease: a case-control study.
- Venous thromboembolism in inflammatory bowel Disease.
- The safety profile of infliximab in patients with Crohn's Disease: the Mayo clinic experience in 500 patients.
- Risk of fracture in Ulcerative colitis: a population-based study from Olmsted County, Minnesota.
- Management of Crohn's Disease of the ileoanal pouch with infliximab.
- Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel Disease treated wit...
- 6-TG for IBD. simple, but safe?
- Gastroduodenal Crohn's Disease: medical management.
- Lymphocytic Colitis: clinical features, treatment, and outcomes.
- Bisphosphonates and the upper gastrointestinal tract: skeletal gain without visceral Pain?
- Fistulas to the urinary System in Crohn's disease: clinical features and outcomes.
- Azathioprine or 6-mercaptopurine before colectomy for Ulcerative colitis is not associated with increased postoperative complications.
- Long-term fracture risk in patients with Crohn's Disease: a population-based study in Olmsted County, Minnesota.
- N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with Ulcerative colitis.
- The fate of low grade dysplasia in Ulcerative colitis.
- Failure to yield: drug resistance in inflammatory bowel Disease.
- Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel Disease.
- Microscopic Colitis: a review.
- The natural history of fistulizing Crohn's Disease in Olmsted County, Minnesota.
- Management of internal fistulas in Crohn's Disease.
- Hereditary angioedema as a cause of transient Abdominal pain.
- Lymphocytic Colitis treated with proctocolectomy and ileal J-pouch-anal anastomosis: report of a case.
- Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel Disease treated with azathioprine or 6-mercaptopurine.
Schools
University Of Mississippi School Of Medicine
Mayo Clinic Rochester
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Colorectal Cancer
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- America's Top Doctors
- Fellow (AGAF)
- Women's Health
- Fellow (FACG)
Education
-
Mayo School of Graduate Medical Education -
University of Mississippi School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1831176841 | |
| NPPES Provider LastName | TREMAINE | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1358.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 64.0 | |
| Percent Opioid Claims | 4.71 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831176841 |
| Last Name Of The Provider | TREMAINE |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Nataliya Razumilava, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas F. Mangan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barham K. Abu Dayyeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maged A. Ghali, MD |
|
|
Dr. J Eileen Hay, MD |
|
|
Dr. Badr F. Al Bawardy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adil E. Bharucha, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Samantha A. Stoven, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Purna C. Kashyap, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence A. Szarka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bret T. Petersen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David H. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh T. Chari, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Margot L. Herman, MD |
|
|
James H. McPherson, MS |